43

DAFTAR PUSTAKA

1. Suleiman M, Hammerman H, Boulos M. Fasting glucose is an important

independent risk factor for 30-day mortality in patients with acute myocardial
infarction: a prospective study. Circulation 2005;111: 754-60.
2. Timmer J, Van der Horst C, Ottervanger JP et al. Prognostic value of
admission glucose in non-diabetic patients with myocardial infarction. Am
Heart J 2004;148:399-404.
3. Brunkhorst F, Engel C, Bloos F. Intensive insulin therapy and pentastarch
resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
4. Iapichino G, Albicini M, Umbrello M. Tight glycemic control does not affect
asymmetric dimethylarginine in septic patients. Intensive Care Med
2008;34:1843-50.
5. Laird A, Miller P, Kilgo P. Relationship of early hyperglycemia to mortality in
trauma patients. J Trauma 2004;56:1058-62.
6. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in
the critically ill patients. N Engl J Med 2001;345: 1359-67.
7. Wiener R, Wiener D, Larson R. Benefits and Risks of Tight Glucose Control
in Critically Ill Adults: a meta-analysis. JAMA 2008;300:933-44.
8. Mitchell I, Knight E, Gissane J et al. A phase II randomised controlled trial of
intensive insulin therapy in general intensive care patients. Crit Care Resusc
2006;8:289-93.
9. NICE-SUGAR Study Investigators. Intensive versus conventional insulin
therapy in critically ill patients. N Engl J Med 2009;360:1283-97.
10. Ali NA, OBrien JM, Blum W. Hyperglycemia in patients with acute myeloid
leukemia is associated with increased hospital mortality. Cancer 2007;110:96102.

44

11. Lacherade J, Jacqueminet S, Preiser J. An overview of hypoglycaemia in the

critically ill. J Diabetes Sci Technol 2009;3:1242-49.
12. Egi M, Bellomo R, Stachowski E et al. Hypoglycemia and outcome in the
critically ill patients. Mayo Clin Proc 2010;85:217-24.
13. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire
S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M,
Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate
blood glucose control by the model predictive control algorithm versus
routine glucose management protocols in intensive care unit patients (Letter).
Diabetes Care 29:19871988, 2006.
14. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz
M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin
therapy in the critically ill patients. N Engl J Med 345: 13591367, 2001.
15. De Block C, Manuel YKB, Van Gaal L, Rogiers P. Intensive insulin therapy
in the intensive care unit: assessment by continuous glucose monitoring.
Diabetes Care. 29:17501756, 2006.
16. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level
and mortality among hospitalized nondiabetic patients with heart failure. Arch
Intern Med 2006;166(15):16131619.[PubMed: 16908794].
17. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive
of outcome in critically ill trauma patients. J Trauma 2005;58(5):921924.
[PubMed: 15920404].
18. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased
risk of death after myocardial infarction in patients with and without diabetes:
a

systematic

10711923].

overview.

Lancet

2000;355(9206):773778.

[PubMed:

45

19. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically
ill patients. JAMA 2003;290(15):20412047. [PubMed: 14559958].
20. Golden SH, Peart-Vigilance C, Kao WH, et al. Perioperative glycemic control
and the risk of infectious complications in a cohort of adults with diabetes.
Diabetes Care 1999;22(9):14081414. [PubMed: 10480501].
21. Reed CC, Stewart RM, Sherman M, et al. Intensive insulin protocol improves
glucose control and is associated with a reduction in intensive care unit
mortality. Journal of the American College of Surgeons 2007;204(5):1048
1054. discussion 1054-1045. [PubMed: 17481538].
22. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for
patients in paediatric intensive care: a prospective, randomised controlled
study. Lancet. 2009.
23. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and
pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125
139. [PubMed: 18184958].
24. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional
insulin therapy: a randomized controlled trial in medical and surgical
critically ill patients. Critical care medicine 2008;36(12):31903197.
[PubMed: 18936702].
25. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose
control in critically ill patients. N Engl J Med 2009;360(13):12831297.
[PubMed: 19318384].
26. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients
hospitalized with acute myocardial infarction: defining the optimal outcomesbased measure of risk. Circulation 2008;117(8):10181027. [PubMed:
18268145].

46

27. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and
hyperglycemia in hospitals. Diabetes Care 2004;27(2):553597. [PubMed:
14747243].
28. Garber AJ, Moghissi ES, Bransome ED Jr. et al. American College of
Endocrinology position statement on inpatient diabetes and metabolic control.
Endocr Pract 2004;10(Suppl 2):49.[PubMed: 15251633].
29. Rady MY, Johnson DJ, Patel BM, et al. Influence of individual characteristics
on outcome of glycemic control in intensive care unit patients with or without
diabetes mellitus. Mayo Clin Proc 2005;80(12):15581567. [PubMed:
16342648].
30. Hafidh SA, Reuter MD, Chassels LJ, et al. Effect of intravenous insulin
therapy on clinical outcomes in critically ill patients. The American journal of
the medical sciences 2007;333(6):354361. [PubMed: 17570988].
31. Malhotra A. Intensive insulin in intensive care. N Engl J Med
2006;354(5):516518. [PubMed:16452564].
32. Herpe TV, Mesotten D. Blood glucose measurements in critically ill patients.
J Diabetes Science and Technology. 2012;6:22-28.
33. Bagshaw SM, Egi M, George C, Bellomo R; Australia New Zealend Intensive
Care Society Database Management Committee. Early blood glucose control
and mortality in critically ill patients in Australia. Crit Care Med.
2009;37(2):46370.
34. Cembrowski GS, Tran DV, Slater-Maclean L, Chin D, Gibney RT, Jacka M.
Could susceptibility to low hematocrit interference have compromised the
results of the NICE-SUGAR trial? Clin Chem. 2010;56(7):11935.
35. Lyon ME, DuBois JA, Fick GH, Lyon AW. Estimates of total analytical error
in consumer and hospital glucose meters contributed by hematocrit, maltose,
and ascorbate. J Diabetes Sci Technol. 2010;4(6):147994.

47

36. Ng WY, Tiong CC, Jacob E. Maltose interference-free test strips for blood
glucose testing at point-of-care: a laboratory performance evaluation.
Diabetes Technol Ther. 2010;12(11):88993.
37. Holzinger U, Warszawska J, Kitzberger R, Wewalka W, Herkner H, Madl C.
Real-time continuous glucose monitoring in critically ill patients: a
prospective randomized trial. Diabetes Care. 2010;33(3):46772.
38. Pradian E. The Effect of dextrose to blood of Glukosa and ketone bodies level
in pediatric Patient underwent labioplasty. The Indonesian Journal of
anesthesiology and Critical Care, Bandung; 2004: 109-117.
39. Waxman K. Physiologic respon to injury. In : shoemaker WC, Holbrook PR,
Ayres SM, Grenvik A. Critical Care. W.B.Saunders Company, Philadelphia,
London, Toronto, 2000: 277-82.
40. Faustino EV, Aphon M. Persistent hyperglycemia in critically ill children. J
Pediatr 2005;146:30-4.
41. Yung M, Wilkins B, Norton L. Glucose control, organ failure, and mortality
in pediatric intensive care. Pediatr Crit Care Med 2008;9:147-52.
42. Branco R.G, Garcia P.C.R, Piva J.P. Glucose level and risk of mortality in
pediatric sepstic shock. Pediatr Crit Care Med 2005; 6: 470-2.
43. Yung M, Wilkins B, Norton L Glucose control, organ failure, and mortality in
pediatric intensive care. Pediatr Crit Care Med 2008;9:147-52.
44. Srinivasan V, Spinella PC, Drott HR. Association of timing, duration,and
intensity of hyperglycemia withintensive care unit mortality ill children.
Pediatr Crit Care Med 2004; 5: 329-36.
45. Leteurtre S, Martinot A, Duhamel A, Proulx F, Granbastien B, Cotting J,
Gottesman R, dkk. Validation of the paediatric logistic organ dysfunction
(PELOD) score: prospective, observational, multicentre study. Lancet 2003;
362:192-7.

48

46. Escallon J. Carbohydrates, proteins and lipids dalam McCarnish M et al,

editors. An integrated approach to patient care total nutritional therapy. 2 nd
ed. Pennsylvania: Elsevier; 2003.p.51-61.
47. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control
in critically ill adults. JAMA 2008;300:933 44.
48. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by
simulation modeling of errors in insulin dose. Clin Chem 2001; 47:209 14.
49. Kimberly MM, Vesper HW, Caudill SP, et al. Variability among five over-thecounter blood glucose monitors. Clin Chim Acta 2006;364:2927.
50. Krouwer JS, Cembrowski GS. A review of standards and statistics used to

describe blood glucose monitor performance. J Diabetes Sci Technol.

2010;4(1):7583.